Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
05 2019
Historique:
received: 07 08 2018
revised: 30 10 2018
accepted: 23 11 2018
pubmed: 7 12 2018
medline: 5 8 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Functional impairment is associated with mortality in adult liver transplant candidates. This has not been studied in pediatric liver transplant candidates. United Network for Organ Sharing Standard Transplant Analysis and Research files were used to investigate functional status, waitlist mortality, and posttransplant outcomes in children younger than 18 years who were waitlisted in 2006-2016 for primary liver transplant. Functional status was categorized, by using the Lansky Play-Performance Scale (LPPS), as normal/good (80-100), moderately impaired (50-70), or severely impaired (10-40) by center assessment. Among 3250 children not listed as Status 1A, 62% had an LPPS score of 80-100, 25% had a score of 50-70, and 13% had a score of 10-40 at listing. Children with an LPPS score of 10-40 at listing were more likely to die while on the waitlist (standardized hazard ratio 1.85, 95% confidence interval 1.09-3.13, P = .02) in analyses adjusting for being on a ventilator, breathing support, or dialysis and other illness severity measures. For the 2565 children transplanted, an LPPS score of 10-40 at listing drastically increased mortality risk by 1 year posttransplant (hazard ratio 5.77, 95% confidence interval 3.05-10.91, P < .0005). LPPS scores of 10-40 and 50-70 both increased the risk of graft loss by 1 year. Functional status is an independent predictor of waitlist and posttransplant mortality in pediatric liver transplant candidates. Validated tools for the assessment of functional status in these children would improve our ability to predict mortality risk-and to appropriately prioritize them for transplant.

Identifiants

pubmed: 30506640
doi: 10.1111/ajt.15203
pmc: PMC6482090
mid: NIHMS999811
pii: S1600-6135(22)09073-6
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1388-1396

Subventions

Organisme : NIA NIH HHS
ID : K23 AG048337
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK026743
Pays : United States
Organisme : School of Medicine, University of California, San Francisco
Pays : International
Organisme : HRSA HHS
ID : 234-2005-37011C
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059183
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK099253
Pays : United States

Informations de copyright

© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

J Hepatol. 2018 Oct;69(4):818-825
pubmed: 29883596
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1189-1195.e1
pubmed: 27046483
Eur J Cancer. 2016 Nov;67:130-140
pubmed: 27662616
J Heart Lung Transplant. 2017 Aug;36(8):890-896
pubmed: 28363739
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):222-226
pubmed: 29356766
Cancer. 1987 Oct 1;60(7):1651-6
pubmed: 3621134
J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):808-12
pubmed: 26655935
J Pediatr. 2018 Mar;194:109-115.e4
pubmed: 29478492
Hepatology. 2017 Jan;65(1):217-224
pubmed: 27775842
Am J Transplant. 2016 Nov;16(11):3181-3191
pubmed: 27214757
Bone Marrow Transplant. 2015 Nov;50(11):1416-23
pubmed: 26237164
Transplantation. 2016 Aug;100(8):1692-8
pubmed: 27314169
Clin Transplant. 2016 Nov;30(11):1403-1410
pubmed: 27439897
Am J Transplant. 2018 Aug;18(8):1986-1994
pubmed: 29380529
Am J Transplant. 2014 Aug;14(8):1870-9
pubmed: 24935609
JAMA Pediatr. 2018 Nov 1;172(11):1070-1077
pubmed: 30242345
J Spinal Cord Med. 2004;27 Suppl 1:S50-3
pubmed: 15503703
Hepatology. 2017 Aug;66(2):564-574
pubmed: 28422306
Am J Transplant. 2018 May;18(5):1187-1196
pubmed: 29116679

Auteurs

Emily R Perito (ER)

Department of Pediatrics, UCSF, San Francisco, California.
Department of Epidemiology and Biostatistics, UCSF, San Francisco, California.

John Bucuvalas (J)

Department of Pediatrics, Recanati-Miller Transplant Institute, Icahn School of Medicine at Mt. Sinai School of Medicine, New York, New York.

Jennifer C Lai (JC)

Department of Medicine, UCSF, San Francisco, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH